Ftse Mib
34.088,40
-0,84%
DAX
18.489,60
-0,59%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.547,12
-3,55%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Mds (MDZ) Mds (MDZ) Notizie

MDZ

Mds (MDZ)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MDZ
DataOraFonteTitoloSimboloCompagnia
14/06/200720:00PR Newswire (US)MDS Inc. and Dr. Donald Rix announce $4,000,000 in Gifts to BC Cancer Foundation and BC Children's Hospital FoundationNYSE:MDZ
07/06/200714:00PR Newswire (US)/FIRST AND FINAL ADD - TO294 - MDS Inc./NYSE:MDZ
07/06/200714:00PR Newswire (US)MDS Reports Second Quarter 2007 ResultsNYSE:MDZ
06/06/200715:00PR Newswire (US)MDS to Present at Goldman Sachs Global Healthcare ConferenceNYSE:MDZ
04/06/200715:00PR Newswire (US)MDS Nordion and University of Ottawa Heart Institute Launch Molecular Imaging Centre of Excellence to Advance Innovative CardiolNYSE:MDZMds
31/05/200715:05PR Newswire (US)Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate DevelopmentNYSE:MDZ
31/05/200715:00PR Newswire (US)MDS to Release Second Quarter ResultsNYSE:MDZ
11/05/200715:00PR Newswire (US)MDS Pharma Services Names Dr. James Pusey to Lead Global Clinical DevelopmentNYSE:MDZ
16/04/200715:00PR Newswire (US)Molecular Devices Introduces New Aequorin Option for Flipr Tetra(R) Screening SystemNYSE:MDZ
16/04/200715:00PR Newswire (US)Molecular Devices Announces the Release of the First Live Cell Kinetic Neurotransmitter Transporter Uptake Assay KitNYSE:MDZ
09/04/200714:00PR Newswire (US)MDS Inc. Announces Results of Share BuybackNYSE:MDZ
04/04/200715:00PR Newswire (US)MDS Nordion Enters Collaboration Agreement with Avid Radiopharmaceuticals on Imaging Compounds for Alzheimer's DiseaseNYSE:MDZMds
28/03/200714:00PR Newswire (US)MDS Completes Acquisition of Molecular DevicesNYSE:MDZ
23/03/200713:00PR Newswire (US)MDS to Present at Scotia Capital's Spring Growth ConferenceNYSE:MDZ
20/03/200713:00PR Newswire (US)MDS to Complete Acquisition of Molecular DevicesNYSE:MDZ
14/03/200714:00PR Newswire (US)MDS Extends Cash Tender Offer for All Outstanding Shares of Molecular Devices CorporationNYSE:MDZ
13/03/200714:00PR Newswire (US)MDS to Present at Tenth Annual Lehman Brothers' Global Healthcare ConferenceNYSE:MDZ
08/03/200713:00PR Newswire (US)/FIRST AND FINAL ADD - TO347 - MDS Inc./NYSE:MDZ
08/03/200713:00PR Newswire (US)MDS Reports First Quarter 2007 ResultsNYSE:MDZ
01/03/200714:30PR Newswire (US)MDS to Release First Quarter ResultsNYSE:MDZ
01/03/200714:00PR Newswire (US)MDS Nordion to Expand Facility to Meet Growing Demand for Medical Imaging Agent in EuropeNYSE:MDZMds
26/02/200713:00PR Newswire (US)MDS Finalizes Sale of Diagnostics Business to Borealis Infrastructure in $1.3B TransactionNYSE:MDZ
20/02/200713:00PR Newswire (US)MDS Announces New Chief Financial OfficerNYSE:MDZ
19/02/200713:00PR Newswire (US)MDS Provides Update on Timing of Diagnostics Transaction ClosingNYSE:MDZ
08/02/200714:00PR Newswire (US)MDS Nordion Establishes European Centers of Excellence for Innovative Liver Cancer TherapyNYSE:MDZMds
05/02/200714:00PR Newswire (US)MDS to Present at UBS Global Healthcare Services ConferenceNYSE:MDZ
01/02/200714:00PR Newswire (US)MDS to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferenceNYSE:MDZ
29/01/200714:00PR Newswire (US)MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex BusinessNYSE:MDZ
17/01/200714:00PR Newswire (US)First Patients in India Receive Innovative Treatment for Primary Liver CancerNYSE:MDZMds
11/01/200703:10PR Newswire (US)FDA Clarifies Path to Review Completion for MDS Bioanalytical ClientsNYSE:MDZMds
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MDZ

La tua Cronologia

LSE
0F3G
Lingotes Especiales
LSE
G500
Ivz S&p Gbp Hdg
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network